Targeted News Service

Auten and Shannon Contribute Chapter on Hatch-Waxman and BPCIA Litigation to Biosimilars Litigation Book
December 20, 2024

MINNEAPOLIS, Minnesota, Dec. 20 -- Taft, a law firm, issued the following news:

Taft Pharmaceutical and Life Sciences Litigation attorneys Steve Auten and Luke Shannon contributed a chapter to the ABA publication "Biosimilars Litigation and Client Counseling." Auten and Shannon authored Chapter 5 - "Notable Differences between Hatch-Waxman and BPCIA Litigation: What Can We Learn?" In this section, Taft partners provide overviews of the Hatch-Waxman Act and the Bi . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form